Many research programs utilize individual peptide compounds to establish consistent evaluation parameters and documented laboratory procedures
IGF1Ec expression in MG-63 human osteoblast-like osteosarcoma cells
Conventional formulations for delivering macromolecules face limitations like insufficient skin penetration and restricted bioavailability
Phase 1a studies in healthy volunteers, published in Diabetes, Obesity and Metabolism in 2023, established the compound's single-dose and multiple-dose pharmacokinetics, confirming a half-life supportive of once-daily dosing, a favorable food-effect profile, and dose-proportional exposure across the tested range
As longevity and preventative medicine become increasingly mainstream, some physicians and patients are exploring a different approach: microdosing, or using lower-than-standard doses of a GLP-1 under medical supervision
1 These agents also delay gastric emptying and reduce appetite via central mechanisms, thereby contributing to their metabolic effects
